Reticulocalbin-1 in clear cell renal cell carcinoma: clinical and functional evidence for its role as a biomarker and potential therapeutic target
Our results confirm that RCN1 is highly and homogenously expressed in ccRCC and correlates with poor prognosis and unfavorable clinicopathological parameters. RCN1 could serve as a reliable biomarker for prognosis in ccRCC and shows potential as a target for therapeutic approaches.
Authors
- Glen Kristiansen (ORCID: https://orcid.org/0000-0003-4149-5487)
- F J Krause
- Manuel Ritter (ORCID: https://orcid.org/0000-0003-0619-0370)
- Michael Stoffel (ORCID: https://orcid.org/0000-0002-4699-5125)
- Jörg Ellinger (ORCID: https://orcid.org/0000-0002-7526-0857)
- Franziska Isabelle Winterhagen
- Marieta Toma (ORCID: https://orcid.org/0000-0002-4803-3712)
Institutions
- University Hospital Bonn (DE)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-09-20
- DOI
- https://doi.org/10.1186/s12885-025-14817-2
- Citations
- 2
- Primary Topic
- Photosynthetic Processes and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 1.61